Effect of incretin-based therapies on cancers of digestive system among 101 595 patients with type 2...
Effect of incretin-based therapies on cancers of digestive system among 101 595 patients with type 2 diabetes mellitus: a systematic review and network meta-analysis combining 84 trials with a median duration of 30 weeks
About this item
Full title
Author / Creator
Chai, Sanbao , Yu, Shuqing , Yang, Zhirong , Wu, Shanshan , Gao, Le , Wang, Haining , Zhang, Yuan , Zhan, Siyan , Ji, Linong and Sun, Feng
Publisher
England: American Diabetes Association
Journal title
Language
English
Formats
Publication information
Publisher
England: American Diabetes Association
Subjects
More information
Scope and Contents
Contents
ObjectivesTo evaluate the risk of cancers of digestive system with incretin-based therapies among patients with type 2 diabetes mellitus.Research design and methodsMedline, Embase, Cochrane Library and ClinicalTrials.gov databases were searched for randomized controlled clinical trials that compared incretin-based drugs with placebo or other antidi...
Alternative Titles
Full title
Effect of incretin-based therapies on cancers of digestive system among 101 595 patients with type 2 diabetes mellitus: a systematic review and network meta-analysis combining 84 trials with a median duration of 30 weeks
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d7330b274c284d909255e77582a779dd
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d7330b274c284d909255e77582a779dd
Other Identifiers
ISSN
2052-4897
E-ISSN
2052-4897
DOI
10.1136/bmjdrc-2019-000728
